TRMU and breast cancer: On the other hand, the overexpression of eight nuclear MTRGs, including TRMU, NDUFA1, NDUFA2, COX14, COX7B, SPG7, DGUOK, and COA5, were significantly correlated with improved prognosis of BC patients (p<0.05, Figure 2A).